Anastasia Polycarpou1, Stephen L Walker, Diana N Lockwood. 1. Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. Anastasia.Polycarpou@lshtm.ac.uk
Abstract
PURPOSE OF REVIEW: This review focuses on recent work in leprosy pathogenesis. New research of both innate and adaptive immune responses to Mycobacterium leprae is described. The proposition that Mycobacterium lepromatosis is a new species causing leprosy is discussed. RECENT FINDINGS: Modulation of the lipid metabolism and reprogramming of adult Schwann cells have both been suggested as mechanisms used by M. leprae to disseminate the disease. New markers associated with localized, disseminated disease or the occurrences of leprosy reactions include the human interferons, CD163, microRNA-21, NOD2, galectin-3 and toll-like receptor 4. The role of keratinocytes instead of macrophages is underlined in the pathogenesis of leprosy. Adaptive immunity reports focus on the role of T regulatory cells and cytokines secreted by T helper cells in leprosy. Finally, a newly identified species named M. lepromatosis has been detected in patients with leprosy and severe erythema nodosum leprosum. SUMMARY: Novel biological pathways have been identified to be associated with the clinical phenotype of leprosy or the occurrence of leprosy reactions. Future work should include larger numbers of clinical samples from across the leprosy spectrum in order to give new insights in the pathogenesis and management of the disease.
PURPOSE OF REVIEW: This review focuses on recent work in leprosy pathogenesis. New research of both innate and adaptive immune responses to Mycobacterium leprae is described. The proposition that Mycobacterium lepromatosis is a new species causing leprosy is discussed. RECENT FINDINGS: Modulation of the lipid metabolism and reprogramming of adult Schwann cells have both been suggested as mechanisms used by M. leprae to disseminate the disease. New markers associated with localized, disseminated disease or the occurrences of leprosy reactions include the human interferons, CD163, microRNA-21, NOD2, galectin-3 and toll-like receptor 4. The role of keratinocytes instead of macrophages is underlined in the pathogenesis of leprosy. Adaptive immunity reports focus on the role of T regulatory cells and cytokines secreted by T helper cells in leprosy. Finally, a newly identified species named M. lepromatosis has been detected in patients with leprosy and severe erythema nodosum leprosum. SUMMARY: Novel biological pathways have been identified to be associated with the clinical phenotype of leprosy or the occurrence of leprosy reactions. Future work should include larger numbers of clinical samples from across the leprosy spectrum in order to give new insights in the pathogenesis and management of the disease.
Authors: Carlos Franco-Paredes; Luis A Marcos; Andrés F Henao-Martínez; Alfonso J Rodríguez-Morales; Wilmer E Villamil-Gómez; Eduardo Gotuzzo; Alexandro Bonifaz Journal: Clin Microbiol Rev Date: 2018-11-14 Impact factor: 26.132
Authors: Saraswoti Khadge; Sayera Banu; Kidist Bobosha; Jolien J van der Ploeg-van Schip; Isabela M Goulart; Pratibha Thapa; Chhatra B Kunwar; Krista E van Meijgaarden; Susan J F van den Eeden; Louis Wilson; Senjuti Kabir; Hymonti Dey; Luiz R Goulart; Janaina Lobato; Washington Carvalho; Yonas Bekele; Kees L M C Franken; Abraham Aseffa; John S Spencer; Linda Oskam; Tom H M Otttenhoff; Deanna A Hagge; Annemieke Geluk Journal: BMC Infect Dis Date: 2015-10-28 Impact factor: 3.090
Authors: Anderson Fuentes Ferreira; Eliana Amorim de Souza; Mauricélia da Silveira Lima; Gabriela Soledad Márdero García; Francesco Corona; Elaine Silva Nascimento Andrade; Sebastião Alves de Sena Neto; Carmelita Ribeiro Filha; Adriana da Silva Dos Reis; Léia Gadelha Teixeira; Alberto Novaes Ramos Journal: Rev Panam Salud Publica Date: 2019-11-06
Authors: Lisa E Emerson; Puneet Anantharam; Feleke M Yehuala; Kassahun D Bilcha; Annisa B Tesfaye; Jessica K Fairley Journal: Int J Environ Res Public Health Date: 2020-08-20 Impact factor: 3.390